Patent details

Basic Information

Publication number:

EP3143995

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP161860416

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

RAPAMYCIN DERIVATIVE FOR THE TREATMENT OF LUNG CANCER

French Title of Invention:

UN DÉRIVÉ DE RAPAMYCINE POUR LE TRAITEMENT DU CANCER DU POUMON

German Title of Invention:

EIN RAPAMYCINDERIVAT ZUR BEHANDLUNG VON LUNGENKREBS

SPC Number:

LUC00122

Dates

Filing date:

18/02/2002

Grant date:

05/12/2018

EP Publication Date:

22/03/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/12/2018

EP B1 Publication Date:

05/12/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

18/02/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/07/2020

 

 

Name:

Novartis Pharma AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

History of Owners

From:

10/06/2020

To:

31/07/2020

Name:

NOVARTIS PHARMA AG

Address:

Forum 1 Novartis Campus, 4056, Basel, Switzerland (CH)

From:

24/05/2019

To:

10/06/2020

Name:

Novartis International Pharmaceutical AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

From:

13/03/2019

To:

24/05/2019

Name:

NOVARTIS INTERNATIONAL PHARMACEUTICAL AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Name:

NOVARTIS PHARMA AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

From:

28/11/2018

To:

13/03/2019

Name:

NOVARTIS AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

O'Reilly, Terence

Address:

Switzerland (CH)

2

Name:

Lane, Heidi

Address:

Switzerland (CH)

3

Name:

Wood, Jeanette Marjorie

Address:

Switzerland (CH)

Licencee

Name:

N.V. Novartis Pharma S.A.

From:

27/03/2019

Address:

Medialaan 40, 1800, Vilvoorde, Belgium (BE)

To:

Priority

1

Priority Number:

0104072

Priority Date:

19/02/2001

Priority Country:

United Kingdom (GB)

2

Priority Number:

0124957

Priority Date:

17/10/2001

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 31/436; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2019/05

Publication date:

11/04/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

MED

Bulletin edition number:

2019/06

Publication date:

06/05/2019

Description:

Section K : Modifications and recordals into the register

3

Bulletin Heading:

CO

Bulletin edition number:

2020/08

Publication date:

13/07/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

201849

Publication date:

05/12/2018

Description:

Grant (B1)

2

Issue number:

201926

Publication date:

26/06/2019

Description:

Transfer of Rights

3

Issue number:

201929

Publication date:

17/07/2019

Description:

Opposition procedure started

4

Issue number:

201940

Publication date:

02/10/2019

Description:

Opposition procedure started

5

Issue number:

201941

Publication date:

09/10/2019

Description:

Opposition procedure started

6

Issue number:

202036

Publication date:

02/09/2020

Description:

Transfer of Rights

7

Issue number:

202120

Publication date:

19/05/2021

Description:

Title of invention Modified

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000121A

Date Registered:

13/03/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

NOVARTIS PHARMA AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

2

Name:

NOVARTIS INTERNATIONAL PHARMACEUTICAL AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Licence

Change Kind/ Decision Type:

New licence registration

Deed Number:

RC20190000141B

Date Registered:

27/03/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Not Exclusive

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Luxembourg (LU)

Updated Licence Number:

Terminated Licence Number:

Added Licencee(s)

Name:

N.V. Novartis Pharma S.A.

Address:

Medialaan 40, 1800, Vilvoorde, Belgium (BE)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20200000167A

Date Registered:

10/06/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

NOVARTIS PHARMA AG

Address:

Forum 1 Novartis Campus, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

10/02/2021

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
01/04/2019	Outgoing Correspondence	1
13/03/2019	Request For Change	6
10/06/2020	Request For Change	12
15/06/2020	Outgoing Correspondence	2
21/03/2019	Outgoing Correspondence	2
27/03/2019	Request For Change	6